StockClub

INDV

INDVIndivior Pharmaceuticals Inc$ --
Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc

INDV

$ -

-

Review earnings summary, surprise history, and upcoming forecasts.

wallet
Earnings Summary
Updated: 12/31/2025FY2025 Q4
Revenue
358M USD
YoY +19.7%
Operating Income
122M USD
YoY +27.1%
Net Income
103M USD
YoY +74.6%
EPS
0.82$
YoY +82.2%

Revenue

$1.2B
FY2024 Q1$284M
$284M
Q1
FY2024 Q2$583M
$583M
Q2
FY2024 Q3$890M
$890M
Q3
FY2024 Q4$1.2B
$1.2B
Q4
FY2025 Q1$266M
$266M
Q1
FY2025 Q2$568M
$568M
Q2
FY2025 Q3$882M
$882M
Q3
FY2025 Q4$1.2B
$1.2B
Q4
Actual
+$51M (+4.3%)

Net Income

$210M
FY2024 Q1$61M
$61M
Q1
FY2024 Q2$-36M
$-36M
Q2
FY2024 Q3$-32M
$-32M
Q3
FY2024 Q4$27M
$27M
Q4
FY2025 Q1$47M
$47M
Q1
FY2025 Q2$65M
$65M
Q2
FY2025 Q3$107M
$107M
Q3
FY2025 Q4$210M
$210M
Q4
Actual
+$183M (+677.8%)

Surprise History

Actual RevenueAnalyst Estimate
FY2020MISS
Actual:$647M
Est:$647.5M
FY2020MISS
$647M
FY2021BEAT
Actual:$791M
Est:$757.9M
FY2021BEAT
$791M
FY2022BEAT
Actual:$901M
Est:$898.7M
FY2022BEAT
$901M
FY2023BEAT
Actual:$1.1B
Est:$1.1B
FY2023BEAT
$1.1B
FY2024BEAT
Actual:$1.2B
Est:$1.2B
FY2024BEAT
$1.2B
FY2025BEAT
Actual:$1.2B
Est:$1.2B
FY2025BEAT
$1.2B

Analyst Estimates